Michael T Lawton1. 1. Department of Neurological Surgery, University of California, San Francisco 94143-0112, USA. lawtonm@neurosurg.ucsf.edu
Abstract
OBJECTIVE: To analyze surgical results for the highly variable Spetzler-Martin Grade III arteriovenous malformations (AVMs), to demonstrate that outcomes vary among the different types of Grade III lesions, and to introduce a simple modification of the grading scale that might improve its usefulness for these AVMs. METHODS: In a consecutive series of 174 brain AVMs resected from 174 patients during a period of 4.8 years, 76 AVMs (45.2%) were Grade III. There were 35 small AVMs (S1V1E1) (46.1%), 14 medium/deep AVMs (S2V1E0) (18.4%), and 27 medium/eloquent AVMs (S2V0E1) (35.5%). No large Grade III AVM (S3V0E0) was treated. RESULTS: Complete AVM resection was accomplished for 74 patients (surgical obliteration rate, 97.4%). Three patients (3.9%) experienced permanent, treatment-associated, neurological morbidity, and three patients died (surgical mortality rate, 3.9%). Good outcomes (Rankin scale scores of <or=2) were observed for 59 patients (78.7%). Surgical risks (new deficit or death), according to the Grade III type, were 2.9% for small AVMs (S1V1E1), 7.1% for medium/deep AVMs (S2V1E0), and 14.8% for medium/eloquent AVMs (S2V0E1). CONCLUSION: Grade III AVMs are a heterogeneous group, with each type possessing different surgical risks, and the Spetzler-Martin grading scale should be modified accordingly. Grade III- AVMs (S1V1E1) have a surgical risk similar to that of low-grade AVMs and can be safely treated with microsurgical resection. Grade III+ AVMs (S2V0E1) have a surgical risk similar to that of high-grade AVMs and are best managed conservatively. Grade III AVMs (S2V1E0) have intermediate surgical risks and require judicious selection for surgery. Grade III* AVMs (S3V0E0) are either exceedingly rare, with a surgical risk that is unclear, or theoretical lesions with no clinical relevance.
OBJECTIVE: To analyze surgical results for the highly variable Spetzler-Martin Grade III arteriovenous malformations (AVMs), to demonstrate that outcomes vary among the different types of Grade III lesions, and to introduce a simple modification of the grading scale that might improve its usefulness for these AVMs. METHODS: In a consecutive series of 174 brain AVMs resected from 174 patients during a period of 4.8 years, 76 AVMs (45.2%) were Grade III. There were 35 small AVMs (S1V1E1) (46.1%), 14 medium/deep AVMs (S2V1E0) (18.4%), and 27 medium/eloquent AVMs (S2V0E1) (35.5%). No large Grade III AVM (S3V0E0) was treated. RESULTS: Complete AVM resection was accomplished for 74 patients (surgical obliteration rate, 97.4%). Three patients (3.9%) experienced permanent, treatment-associated, neurological morbidity, and three patients died (surgical mortality rate, 3.9%). Good outcomes (Rankin scale scores of <or=2) were observed for 59 patients (78.7%). Surgical risks (new deficit or death), according to the Grade III type, were 2.9% for small AVMs (S1V1E1), 7.1% for medium/deep AVMs (S2V1E0), and 14.8% for medium/eloquent AVMs (S2V0E1). CONCLUSION: Grade III AVMs are a heterogeneous group, with each type possessing different surgical risks, and the Spetzler-Martin grading scale should be modified accordingly. Grade III- AVMs (S1V1E1) have a surgical risk similar to that of low-grade AVMs and can be safely treated with microsurgical resection. Grade III+ AVMs (S2V0E1) have a surgical risk similar to that of high-grade AVMs and are best managed conservatively. Grade III AVMs (S2V1E0) have intermediate surgical risks and require judicious selection for surgery. Grade III* AVMs (S3V0E0) are either exceedingly rare, with a surgical risk that is unclear, or theoretical lesions with no clinical relevance.
Authors: M Cronqvist; R Wirestam; B Ramgren; L Brandt; B Romner; O Nilsson; H Säveland; S Holtås; E-M Larsson Journal: AJNR Am J Neuroradiol Date: 2006-01 Impact factor: 3.825
Authors: Rene O Sanchez-Mejia; Michael W McDermott; Jeffery Tan; Helen Kim; William L Young; Michael T Lawton Journal: Neurosurgery Date: 2009-02 Impact factor: 4.654
Authors: Helen Kim; Adib A Abla; Jeffrey Nelson; Charles E McCulloch; David Bervini; Michael K Morgan; Christopher Stapleton; Brian P Walcott; Christopher S Ogilvy; Robert F Spetzler; Michael T Lawton Journal: Neurosurgery Date: 2015-01 Impact factor: 4.654
Authors: Antonio Nicolato; Roberto Foroni; Andrea Seghedoni; Valentina Martines; Francesco Lupidi; Piergiuseppe Zampieri; Marco F Sandri; Umberto Ricci; Carlo Mazza; Alberto Beltramello; Massimo Gerosa; Albino Bricolo Journal: Childs Nerv Syst Date: 2005-01-15 Impact factor: 1.475